Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharming Group NV
Accounts Payable Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Accounts Payable
$72.6m
CAGR 3-Years
26%
CAGR 5-Years
16%
CAGR 10-Years
29%
ProQR Therapeutics NV
NASDAQ:PRQR
Accounts Payable
€33k
CAGR 3-Years
-52%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Accounts Payable
$5.4m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
1%
argenx SE
XBRU:ARGX
Accounts Payable
$280.6m
CAGR 3-Years
5%
CAGR 5-Years
38%
CAGR 10-Years
62%
Merus NV
NASDAQ:MRUS
Accounts Payable
$6.2m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Accounts Payable
$4.4m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Accounts Payable?
Accounts Payable
72.6m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Accounts Payable amounts to 72.6m USD.

What is Pharming Group NV's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
29%

Over the last year, the Accounts Payable growth was 16%. The average annual Accounts Payable growth rates for Pharming Group NV have been 26% over the past three years , 16% over the past five years , and 29% over the past ten years .

Back to Top